Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26115797

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Aug
First author
Oza AM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Aug;16(8):876-8. doi: 10.1016/S1470-2045(15)00064-9.
    note
    Source null
    related pmid
    26115795
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Oct;16(13):e478-9. doi: 10.1016/S1470-2045(15)00311-3.
    note
    Source null
    related pmid
    26433820
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2015 Oct;16(13):e478. doi: 10.1016/S1470-2045(15)00283-1.
    note
    Source null
    related pmid
    26433821
    relationship
    Comment in

Authors and identifiers

  1. name
    Oza AM
    type
    Author
  2. name
    Cook AD
    type
    Author
  3. name
    Pfisterer J
    type
    Author
  4. name
    Embleton A
    type
    Author
  5. name
    Ledermann JA
    type
    Author
  6. name
    Pujade-Lauraine E
    type
    Author
  7. name
    Kristensen G
    type
    Author
  8. name
    Carey MS
    type
    Author
  9. name
    Beale P
    type
    Author
  10. name
    Cervantes A
    type
    Author
  11. name
    Park-Simon TW
    type
    Author
  12. name
    Rustin G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Oza AM
    type
    Author
  2. name
    Cook AD
    type
    Author
  3. name
    Pfisterer J
    type
    Author
  4. name
    Embleton A
    type
    Author
  5. name
    Ledermann JA
    type
    Author
  6. name
    Pujade-Lauraine E
    type
    Author
  7. name
    Kristensen G
    type
    Author
  8. name
    Carey MS
    type
    Author
  9. name
    Beale P
    type
    Author
  10. name
    Cervantes A
    type
    Author
  11. name
    Park-Simon TW
    type
    Author
  12. name
    Rustin G
    type
    Author
bibliography ids
  1. nci-bib-5326c14a40ff866e122b0cb9
book metadata
content sha256
58f04b1cd9e5453b8d36720c5b5c4b3076ce2ee9e8cf60be05fa39ae6eef5f69
document type
citation
dois
  1. 10.1016/S1470-2045(15)00086-8
electronic publication date
display
2015 Jun 23
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26115797
immutable id
pubmed:26115797@58f04b1cd9e5453b8d36720c5b5c4b3076ce2ee9e8cf60be05fa39ae6eef5f69
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
928-36
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Aug;16(8):876-8. doi: 10.1016/S1470-2045(15)00064-9.
    note
    Source null
    related pmid
    26115795
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Oct;16(13):e478-9. doi: 10.1016/S1470-2045(15)00311-3.
    note
    Source null
    related pmid
    26433820
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2015 Oct;16(13):e478. doi: 10.1016/S1470-2045(15)00283-1.
    note
    Source null
    related pmid
    26433821
    relationship
    Comment in
outcomes validated
false
pmid
26115797
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
b58e65d47fa821fd28ca47c26a28ff96adcbfde258273ccbe835b67d82b5b127
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Aug
precision
month
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26115797/
title
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Preserved source evidence · Not medical advice